In addition to this, it is worth noting that except for 2020, the percentage of CPGNB from internal medicine sources is in an increasing trend, from 30.46% in 2019 to 31.25% in 2021, to 39.21% in 2022 and 42.65% in 2023, where it even surpasses the ICU as the departmental division with the highest percentage in 2022, which may portend the growing drug resistance potential in internal medicine.
← all excerpts
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.
1
—
—